Previously here at Mint Message, we talked about the development of a job known as LOY-001 to extend the life of dogs and give them more time to be with their owners. A biotech company is developing this drug and it is currently in tests and clinical trials with the United States Food and Drug Administration.
"Today, I'm so proud to announce that Loyal has earned what we believe to be the FDA's first-ever formal acceptance that a drug can be developed and approved to extend lifespan," writes the founder and CEO of the Loyal for Dogs biotech company wrote in a press release on November 28th, "In regulatory parlance, we have completed the technical effectiveness portion of our conditional approval application for LOY-001's use in large dog lifespan extension."
One of the things that we have forgotten to talk about is that there are also other versions of the drug that are being developed in addition to LOY-001 that are being developed by the company in order to extend the lives of different dog breeds. There are the drugs LOY-002 and LOY-003 which are being developed to also be able to reduce the aging process when it comes to dogs.
What is the difference between these drugs? Well, the biggest difference is how the dogs are supposed to take the drugs. LOY-001 is to be administered by injections that will be given to dogs every three to six months by professional vets. Meanwhile, LOY-002 and LOY-003 are being developed in the form of oral pills that are to be given daily to your pets.